Power Law company profile

Allakos

Biotech & Life Sciences · San Carlos, United States · Founded 2012 · IPO 2018 Unicorn

Antibody-based therapeutics to treat various allergies and diseases

Headcount

<100

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

9 investors on Allakos's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 4 investors entered at this stage

Alta Partners

RiverVest Venture Partners

Roche Venture Fund

Novo Ventures

Series B+ 5 investors entered at this stage

NEA

PFM Health Sciences

LifeSci Venture Partners

Redmile Group

Rock Springs Capital

Global footprint

Where Allakos has talent and traffic

Workforce by country

3 countries with
team presence

🇺🇸 United States97.5%

🇮🇳 India3%

🇨🇦 Canada2%

3 countries shown

Web traffic by country

1.6K monthly visits
across markets

🇺🇸 United States100%

Top 1 markets shown

Patent intelligence

$11M patent portfolio · 9 active families

Estimated portfolio value

$11M

623.5× smaller than top peer Janssen Vaccines ($7.1B)

9 active patent families

Where Allakos innovates SIGLECAntiendomysial antibodiesMolecular biologyAnti antibodyPathology

Where Allakos concentrates vs peers

Each axis is a top-10 topic across Allakos and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Allakos

An AI-synthesized read of the highest-engagement posts about Allakos on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Allakos on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles